INDEPENDENT CITIZENS’ OVERSIGHT COMMITTEE (“ICOC”)
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (CIRM)

Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

OPEN SESSION

1. Call to Order.
2. Pledge of Allegiance.
3. Roll Call.

   [Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.]

1. Call to Order.
2. Pledge of Allegiance.
3. Roll Call.

   [Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.]

CONSENT ITEMS

4. Approval of minutes from April 7, 2005 ICOC meeting.

REGULAR ITEMS

5. Chairman’s Report. Letters re. SCA 13
6. President’s Report.
7. Consideration of Site Search Subcommittee’s recommendation for permanent site for California Institute for Regenerative Medicine. Additional Site Recommendation Information
   1. List of Bidders
   2. Score Sheet
   3. Preferences Points
   4. Disqualifications
   5. Revised Points
   6. Round 2 Score Sheet
   7. Site Visit Scores
8. Consideration of Working Group issues and policies including but not limited to Conflict of Interest Policy for Facilities Working Group, Meeting Policy for Standards Working Group and having patient advocate members serve as Working Group Chairs, Co-Chairs or Vice-Chairs.

CLOSED SESSION

9. 1. Personnel: Search for President of the California Institute for Regenerative Medicine (Government Code section 11126, subdivision (a); Health & Safety Code section 125290.30(d)(3)(D)).
   2. Pending Litigation: People’s Advocate v. Independent Citizens’ Oversight Committee, Alameda County Superior Court, Case No. HG05206766 (Government Code section 11126, subdivision (e)).

OPEN SESSION

10. Public report of any action taken, if necessary, during closed session.
11. Consideration of CIRM Training Grants Program for future stem cell researchers. Draft Training Grant RFA
12. Consideration of status report from Standards Working Group Search Subcommittee, including but not limited to consideration of appointment of members (ICOC Patient Advocates, Scientists, and Medical Ethicists) to the Standards Working Group.
13. Consideration of status report from Grants Working Group Search Subcommittee, including but not limited to consideration of appointment of members (ICOC Patient Advocates and Scientists) to the Grants Working Group.Flow Chart: Grants WG Selection Process
14. Consideration of Status report from Facilities Working Group Search Subcommittee including the possibility of a Case Study Model for facilities grants.
15. Consideration of CIRM operating budget.
    1. CIRM Update to Legis. Budget Committee
    2. Projected Expenditures Through Nov. 1, 2005
    3. Projected Expenditures and Bond Funding
16. Consideration of CIRM organizational chart.
17. Consideration of status report from Presidential Search Subcommittee.
18. Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.
19. Adjournment.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov.